Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

• Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting.

Nyckelord

Administration

Inhalation

Bronchodilator Agents

administration & dosage

pharmacology

therapeutic use

Child

Dose-Response Relationship

Drug

Humans

Hypertension

Pulmonary

drug therapy

Infant

Newborn

Infant

Premature

Nitric Oxide

administration & dosage

pharmacology

therapeutic use

Persistent Fetal Circulation Syndrome

drug therapy

Respiratory Distress Syndrome

Adult

drug therapy

Treatment Outcome

Administration; Inhalation

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)